MEDV_Multi-Pipette_2000px
MEDV_Multi-Pipette_2000px
4871untreatedbone20x
MEDV_Labor-Dietrich__2000px.jpeg
previous arrow
next arrow

Sascha Dietrich, Heidelberg University Hospital

Topic: An Integrated Systems Medicine Approach to Personalized and Targeted Therapy in Lymphoma (Sympathy)
Website: www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-krehl-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/research-group-dietrich/

Marieke Essers, DKFZ and HI-STEM

Topic: Inflammatory Stress in Stem Cells
Website: www.dkfz.de/en/aktivierung-haematopoetische-stammzellen/index.php

Stefan Fröhling, NCT / DKFZ

Topic: Cancer genomics, precision oncology, molecular pathogenesis and therapeutic targeting of myeloid neoplasms and bone and soft-tissue sarcoma
Website: www.nct-heidelberg.de/das-nct/kernbereiche/translationale-medizinische-onkologie.html
www.precisiononcology.de

Stefanie Göllner, Heidelberg University Hospital

Topic: Epigenomics, Epitranscriptomics and novel therapy approaches in AML
Website: www.klinikum.uni-heidelberg.de/personen/dr-med-stefanie-goellner-5361/detail/Person/

Stefan Gröschel, Heidelberg University Hospital, DKFZ and NCT

Topic: Our scientific objectives are to understand pathways of gene regulation and to develop insights with innovate technologies to control gene expression in cancers driven by EVI1, most prominently acute myeloid leukemia. Together with collaboratives from our group and industry alliances we aim to translate these ideas as cancer therapeutic strategies.
Website: www.dkfz.de/en/molekulare-leukaemogenese/index.php
www.klinikum.uni-heidelberg.de/personen/dr-med-stefan-groeschel-3063/detail/Person/

Simon Haas, HI-STEM and DKFZ

Topic: Hematopoietic stem cells, Systems immunology, Single-cell approaches, Technology development, Leukemia research
Website: www.hi-stem.de/research-haas

Wolf-Karsten Hofmann, Heidelberg University, Medical Faculty Mannheim - University Medical Centre Mannheim

Topic: Myelodysplastic Syndrome, Myeloid Neoplasms, Molecular Genetics
Website: www.umm.uni-heidelberg.de/forschung/forschungsschwerpunkte/onkologie/mitglieder/prof-dr-wolf-k-hofmann/

Michael Hundemer, Heidelberg University Hospital

Topic: Hematological Diagnostics, Development of new diagnostic approaches
Website: www.klinikum.uni-heidelberg.de/personen/priv-doz-dr-med-michael-hundemer-3048/detail/Person/

Alwin Krämer, Heidelberg University Hospital, DKFZ and NCT

Topic: Clonal heterogeneity and novel therapy approaches in AML
Website: www.dkfz.de/en/mol-haem_onk/

Katharina Kriegsmann, Heidelberg University Hospital

Topic: Biobanking
Website: www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-krehl-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/

Daniel Lipka, DKFZ & NCT

Topic: Cancer Epigenomics, Biomarker Discovery, Precision Oncology, Myeloid Neoplasms, Normal Hematopoiesis
Website: www.dkfz.de/en/CanEpi/Regulation_of_cellular_differentiation.html
www.nct-heidelberg.de/en/the-nct/core-areas/translational-medical-oncology

Daniel Mertens, DKFZ

Topic: Epigenetics for leukemia patient stratification and microenvironment as a therapeutic target
Website: www.dkfz.de/en/leukemogenesis/index.php
www.mertens-lab.de

Michael Milsom, DKFZ and HI-STEM

Topic: Molecular remodelling of normal HSCs during ageing, stress and leukemogenesis.
Website: www.dkfz.de/en/experimentelle-haematologie/index.php
www.hi-stem.de/experimental-hematology

Carsten Müller-Tidow, Heidelberg University Hospital

Topic: Epigenomics, Epitranscriptomics and novel therapy approaches in AML
Website: www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-krehl-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/ag-epigenomics-epitranscriptomics-and-novel-therapy-approaches-in-aml/

Daniel Nowak, Heidelberg University, Medical Faculty Mannheim - University Medical Centre Mannheim

Topic: Myeloid neoplasms, high throughput molecular methodology / next generation sequencing, Molecular Tumorboard, pre-clinical mouse models of myeloid neoplasms, clinical trials.
Website: www.umm.uni-heidelberg.de/forschung/forschungsschwerpunkte/onkologie/mitglieder/prof-dr-daniel-nowak/

Caroline Pabst, Heidelberg University Hospital

Topic: Identification of leukemia propagating genetic networks in primary human leukemic stem cells
Website: www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-krehl-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/ag-pabst-max-eder-nachwuchsgruppe/eng-max-eder-junior-research-group-pabst/

Simon Raffel, Heidelberg University Hospital

Topic: Metabolic Vulnerabilities of Acute Myeloid Leukemia Stem Cells
Website: https://www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-medizin-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/emmy-noether-ag-raffel/

Karsten Rippe, DKFZ

Topic: The goal of the group is to provide an integrated view on how the dynamic balance between different chromatin states determines genome functions. Our work has a number of implications for translational medical research with respect to elucidating the complex effects of epigenetic drugs like histone deacetylase or DNA methylase inhibitors in treatment of cancer.
Website: https://www.dkfz.de/en/chromatin-networks

Tim Sauer, Heidelberg University Hospital

Topic: Chimeric Antigen Receptors (CARs) for the treatment of Acute myeloid leukemia (AML)

Richard Schlenk, Heidelberg University Hospital and NCT

Topic: Clinical trials, innovative study designs, pharmacogenomics, measurable residual disease, liquid biopsies
Website: www.klinikum.uni-heidelberg.de/en/personen/prof-dr-med-richard-schlenk-5837/detail/Person/

Claudia Scholl, DKFZ and NCT Heidelberg

Topic: Discovery of functional dependencies in acute myeloid leukemia
Website: www.dkfz.de/en/angewandte-funktionelle-genomik/index.php

Martina Seiffert, DKFZ

Topic: Immune microenvironment in B-cell lymphoma
Website: www.dkfz.de/en/genetics/pages/projects/CLL/CLL-en.html

Andreas Trumpp, HI-STEM and DKFZ

Topic: Hematopoietic and Leukemic Stem Cells, Therapy Resistance and Minimal Residual Disease (MRD)
Website: www.hi-stem.de/

Judith Zaugg, EMBL

Topic: Regulatory genomics and epigenetics to understand the contribution of the bone marrow niche on ageing and AML
Website: www.zaugg.embl.de